Dr Reddy’s is collaborating with the Indian government’s biotechnology department to conduct Sputnik V vaccine clinical trials In India, after it received approval from the DCGI. Pfizer’s CEO has offered an update on the development and distribution of the COVID-19 vaccine that it is developing in partnership with BioNTech. Cipla has launched COVID-19 antibody detection kits for India. And the WHO has called for management of the coronavirus “infodemic.”

While Dr Reddy’s partners with Fujifilm Toyama for favipiravir for the Indian market, Pfizer and Gilead join together to increase the manufacturing and supply of investigational antiviral treatment remdesivir. Mylan donates a million dollars to Sesame Workshop to provide socio-emotional support to children and families to cope with the uncertainties caused by COVID-19, while Glenmark introduces a higher strength of Fabiflu for the Indian market.

 To increase transparency and affordability, American billionaire and businessman Mark Cuban has launched a US generics venture under the name ‘the Mark Cuban Cost Plus Drugs Company.’ Cuban’s new company is hoping to introduce over 100 drugs by the end of 2021 and build a pharmaceutical factory of its own by 2022.